Scholar Rock Holding (SRRK) Total Liabilities (2017 - 2026)

Scholar Rock Holding's (SRRK) quarterly Total Liabilities came in at $259.2 million in Q1 2026, up 172.25% year-on-year from $95.2 million in Q1 2025, and up 63.27% quarter-over-quarter from $158.8 million in Q4 2025.

Scholar Rock Holding (SRRK) Total Liabilities (2017 - 2026) Analysis & Trends

Scholar Rock Holding's Total Liabilities history runs 10 years deep, the most recent figure standing at $259.2 million for Q1 2026.

  • On a quarterly basis, Total Liabilities rose 172.25% year-over-year to $259.2 million in Q1 2026; TTM through Mar 2026 was $259.2 million, a 172.25% increase from a year earlier, with the FY2025 full-year figure at $158.8 million, up 49.39% from the prior year.
  • Total Liabilities improved to $259.2 million in Q1 2026 per SRRK's latest filing, from $158.8 million in the prior quarter.
  • Across five years, Total Liabilities topped out at $259.2 million in Q1 2026 and bottomed at $82.4 million in Q2 2023.
  • The 5-year median for Total Liabilities is $95.2 million (2025), against an average of $111.3 million.
  • Across the five-year window, Total Liabilities retreated 26.02% in 2022 and jumped 172.25% in 2026, its largest moves.
  • Year by year, Total Liabilities stood at $97.9 million in 2022, then slipped by 12.37% to $85.8 million in 2023, then increased by 23.85% to $106.3 million in 2024, then surged by 49.39% to $158.8 million in 2025, then surged by 63.27% to $259.2 million in 2026.
  • Per Business Quant, the three latest SRRK Total Liabilities figures stand at $259.2 million (Q1 2026), $158.8 million (Q4 2025), and $166.7 million (Q3 2025).

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Total Liabilities (Qtr)
1 Oculis Holding AG 68,785.72 Bn 68,785.72 Bn - 60.46 Mn
2 Nanobiotix 1,895.57 Bn 1,895.51 Bn - 177.22 Mn
3 BeOne Medicines 471.35 Bn 466.56 Bn 1.35 Bn 3.79 Bn
4 NuCana 279.75 Bn 279.75 Bn - 7.33 Mn
5 Vertex Pharmaceuticals 120.24 Bn 113.00 Bn 2.59 Bn 7.12 Bn
6 Regeneron Pharmaceuticals 67.80 Bn 59.04 Bn 3.31 Bn 9.45 Bn
7 Belite Bio 62.51 Bn 62.51 Bn - 15.48 Mn
8 Argenx Se 57.38 Bn 57.38 Bn 1.41 Bn 1.62 Bn
9 Revolution Medicines 37.78 Bn 37.78 Bn - 753.82 Mn
10 Scholar Rock Holding 6.30 Bn 6.30 Bn - 259.24 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 259.24 Mn
Dec 31, 2025 158.78 Mn
Sep 30, 2025 166.72 Mn
Jun 30, 2025 106.75 Mn
Mar 31, 2025 95.22 Mn
Dec 31, 2024 106.29 Mn
Sep 30, 2024 99.94 Mn
Jun 30, 2024 93.25 Mn
Mar 31, 2024 84.51 Mn
Dec 31, 2023 85.82 Mn
Sep 30, 2023 83.02 Mn
Jun 30, 2023 82.40 Mn
Mar 31, 2023 86.07 Mn
Dec 31, 2022 97.93 Mn
Sep 30, 2022 97.04 Mn
Jun 30, 2022 94.62 Mn
Mar 31, 2022 94.66 Mn
Dec 31, 2021 132.37 Mn
Sep 30, 2021 111.13 Mn
Jun 30, 2021 115.40 Mn